Laurence N. Charney - 06 Aug 2026 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Reporting relationship: Director
Issuer ticker: TGTX
Reported as of: 06 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2026, 17:00:53 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurence N. Charney

Key filing fact

Laurence N. Charney filed Form 4 for TG THERAPEUTICS, INC. (TGTX) on 07 Aug 2026.

Key facts

This page summarizes Laurence N. Charney's Form 4 filing for TG THERAPEUTICS, INC. (TGTX).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Aug 2026, 17:00.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001407451 Primary reporting owner

Charney Laurence N

Relationship: Director
Address: 3020 CARRINGTON MILL BLVD, SUITE 475, MORRISVILLE
Signature: /s/ Laurence N. Charney
Signature date: 07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TGTX transaction

Common Stock

Gift

Transaction value
Shares: -5,100
Change %: -2.8%
Price: $0.000000^*
Shares after: 174,590
Date: 06 Aug 2026
Ownership: Direct
Footnotes: F1, F2

TGTX transaction

Common Stock

Gift

Transaction value
Shares: -500
Change %: -0.29%
Price: $0.000000^*
Shares after: 174,090
Date: 07 Aug 2026
Ownership: Direct
Footnotes: F1, F2

TGTX transaction

Common Stock

Gift

Transaction value
Shares: -450
Change %: -0.26%
Price: $0.000000^*
Shares after: 173,640
Date: 07 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

1. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction.

Footnote F2

2. Includes shares of restricted Common Stock, which vest over various time periods.